224 related articles for article (PubMed ID: 3754108)
21. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Wang WH; Li YX; Song YW; Jin J; Liu YP; Wang SL; Zhou LQ; Liu XF; Yu ZH; Han JZ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):218-21. PubMed ID: 16875611
[TBL] [Abstract][Full Text] [Related]
22. Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
Abdallah JM; Lombardi DP; Kirsch IR
J Clin Invest; 1995 Dec; 96(6):2744-7. PubMed ID: 8675643
[TBL] [Abstract][Full Text] [Related]
23. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
[No Abstract] [Full Text] [Related]
24. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
25. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Tsushita K; Utsumi M; Shimoyama M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
[TBL] [Abstract][Full Text] [Related]
26. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Gobbi PG; Pieresca C; Cavanna L; Corbella F; Vallisa D; Federico M; Formisano R; Carotenuto M; Merli F; Callea V; Angrilli F; Silingardi V
Haematologica; 1996; 81(6):503-12. PubMed ID: 9009437
[TBL] [Abstract][Full Text] [Related]
27. The cure of Hodgkin's disease with drugs.
DeVita VT; Hubbard SM; Moxley JH
Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
[No Abstract] [Full Text] [Related]
28. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Karkantaris C; Anargyrou K; Boutsis DE; Variamis E; Michalopoulos T; Boussiotis VA; Panayiotidis P; Papavassiliou C; Pangalis GA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):765-81. PubMed ID: 15183480
[TBL] [Abstract][Full Text] [Related]
29. Plasma and leukocytic bactericidal activity in the course of chemotherapy of Hodgkin's disease.
Wysocka J; Kemona H; Prokopowicz J; Kiluk S
Acta Med Pol; 1987; 28(1-4):99-107. PubMed ID: 3506375
[No Abstract] [Full Text] [Related]
30. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M
J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934
[TBL] [Abstract][Full Text] [Related]
31. [The role of radiotherapy in the treatment of Hodgkin's disease].
Saito Y; Hirose J; Chohtoh S; Nishijima H; Kobayashi A; Kamimura R; Takashima T; Ohtake S; Yoshida T; Nakamura S
Gan No Rinsho; 1985 Dec; 31(15):1899-904. PubMed ID: 3841562
[TBL] [Abstract][Full Text] [Related]
32. [Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma].
Podol'skiĭ PN; Datsenko PV; Pan'shin GA; Sotnikov VM; Mel'nik IuD; Ivashin AV; Bozhenko VK
Vopr Onkol; 2009; 55(4):447-50. PubMed ID: 19947368
[TBL] [Abstract][Full Text] [Related]
33. Hodgkin's disease, intracranial involvement. Report of a case and review of the literature.
Vera R; Enriquez R; Papac R
Am J Clin Oncol; 1985 Feb; 8(1):73-6. PubMed ID: 3838852
[TBL] [Abstract][Full Text] [Related]
34. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
[TBL] [Abstract][Full Text] [Related]
35. Second malignant tumours in childhood Hodgkin's disease.
Jenkin D; Greenberg M; Fitzgerald A
Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
[TBL] [Abstract][Full Text] [Related]
36. Early-stage Hodgkin's disease: current approaches to treatment.
Rusthoven JJ; MacKenzie R
Can Med Assoc J; 1985 Aug; 133(3):193-8. PubMed ID: 3893668
[TBL] [Abstract][Full Text] [Related]
37. Case report: multiagent chemotherapy of Hodgkin's disease associated with red cell aplasia, acquired ichthyosis and anhidrosis.
Homeida M; Mukhtar ED; Daneshmend T; Omer A
East Afr Med J; 1987 May; 64(5):339-41. PubMed ID: 3125033
[No Abstract] [Full Text] [Related]
38. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Olweny CL; Ziegler JL
N Engl J Med; 2008 Feb; 358(7):742; author reply 743. PubMed ID: 18272899
[No Abstract] [Full Text] [Related]
40. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
